FutureScot
Health & Care

Amazon is using its logistics network to support government

Amazon are working to support the UK Government using their logistics networks to deliver test kits to the homes of essential workers. Amazon teams worldwide are working around the clock to ensure they continue to provide important services, while keeping staff safe. This includes a new effort with the UK Government where industry partners, universities and research institutes are lending expertise to boost testing capacity. This collaboration will complement the existing testing programmes in place and aims to add new testing capacity with the creation of additional hub laboratories, test centres and a delivery service for home testing. Amazon are proud to be supporting this initiative, leveraging our logistics network to deliver test kits to homes around the country. This will ensure those not able to travel to a test centre can still take a test. Amazon are waiving fees and providing this service free of charge. Other partners for the initiative include Thermo Fisher Scientific, Boots, Royal Mail and Randox, alongside the Wellcome Trust and top UK universities. In addition, Amazon is supporting other efforts in the UK and around the world to address the crisis, including AWS working closely with the World Health Organisation to accelerate the effort to track the virus, understand its outbreak and to better contain its spread. AWS is also helping to provide infrastructure and technology to enable NHSX – a joint unit between the Department of Health and Social Care, NHS England and NHS Improvement – to quickly and securely launch a Covid-19 response platform for critical public services. You can read more about these initiatives here.

Related posts

Two Scottish islands added to list of remote locations served by personalised wellbeing and digital health programme

Kevin O'Sullivan
September 11, 2019

Virtual wards will play a key part in the future of healthcare

Access Health, Support and Care
March 23, 2023

How tech can prompt medical insights

Kevin O'Sullivan
November 5, 2024
Exit mobile version